COMMUNIQUÉS West-GlobeNewswire

Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies
11/11/2025
Target Loadings of 4% and 5% Rapamycin Achieved for Topical Lotion and Dermal Patch Delivery Technologies Respectively Clinical Trial and Stability Batch Manufacture to Commence in Q4 2025 Clinical Testing in a Number [...]
rYojbaba Co., Ltd. Joins Guardian Girls International (GGI) as an Official Partner for the Guardian Girls Ju-Jitsu Project
11/11/2025
FUKUOKA, Japan, Nov. 11, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”) , a Japanese labor consulting and health services company, building on its previously announced [...]
Alpha Tau to Participate at Jefferies Global Healthcare Conference in London
11/11/2025
JERUSALEM, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced [...]
Lexicon Pharmaceuticals to Participate at the Jefferies 2025 London Healthcare Conference
11/11/2025
THE WOODLANDS, Texas, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the Jefferies 2025 London Healthcare [...]
Solid Biosciences to Participate at Upcoming Investor Conferences
11/11/2025
CHARLESTOWN, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac [...]
Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare
11/11/2025
Pluri launches wholly-owned health and aesthetics subsidiary Cellav- leveraging Pluri’s proprietary 3D cell expansion platform to deliver advanced exosome-based technologies for medical aesthetics The partnership with [...]
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
11/11/2025
BRISBANE, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, [...]
Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine
11/11/2025
Turn’s Topical IL36/IL31 Inhibitor Named Alongside Other Phase 2 & 3 Candidates from Amgen, Sanofi, Leo Pharma, Apogee Therapeutics, and Nektar Therapeutics LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Turn [...]
Daré Bioscience Highlights Commercial Launch Readiness for DARE to PLAY™ Sildenafil Cream; November 17th Webinar to Feature Leading Clinicians Discussing Clinical Data and Potential Impact in Women’s Sexual Health
11/11/2025
Event to Explore What Makes DARE to PLAY™ a First-of-Its-Kind Topical Sildenafil Cream for Women, Review Supporting Clinical Data, and Discuss 503B Pathway to Commercial Availability, Expected Before Year-End SAN DIEGO [...]
RadNet Acquires CIMAR UK, Empowering DeepHealth to Accelerate AI-Powered Imaging, Reporting and Image-Based Screening
11/11/2025
Acquisition supplements CIMAR’s cloud-native infrastructure with DeepHealth’s AI-powered informatics to deliver connected, efficient and accessible care LOS ANGELES and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- RadNet, [...]
Applied StemCell Demonstrates Efficient Knock-In of a 50 kb DNA Construct into Human iPSCs Using TARGATT™ Technology
11/11/2025
MILPITAS, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Applied StemCell, Inc. (ASC), today announced the successful knock-in of a 50 kilobase (kb) multifunctional DNA insert into human induced pluripotent stem cells (iPSCs [...]
Coloplast A/S - Notice of Annual General Meeting 2025
11/11/2025
Notice of Annual General Meeting 2025 The Annual General Meeting of Coloplast A/S will be held on Thursday, 4 December 2025 at 3:30 pm CET at the premises of Coloplast A/S, Holtedam 3 in Humlebæk (the Aage Louis-Hansen [...]
Ariceum Therapeutics Doses First Patient in SANTANA-225 Phase 1/2 Clinical Trial of 225Ac-SSO110 in Patients with Extensive-Stage Small Cell Lung Cancer or Merkel Cell Carcinoma
11/11/2025
225Ac-SSO110 has received U.S. FDA Orphan Drug Designation Initial safety data from SANTANA-225 in ES-SCLC and MCC expected in 2026 Potential to address a broad range of neuroendocrine cancers BERLIN, Nov. 11, 2025 ( [...]
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
11/11/2025
BOSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the pricing of an [...]
Canadian Red Cross sending emergency medical clinic to Jamaica
11/11/2025
Humanitarian experts deploying to help people impacted by Hurricane Melissa OTTAWA, Ontario, Nov. 10, 2025 (GLOBE NEWSWIRE) -- In response to the devastating impact of Hurricane Melissa across the Caribbean region, the [...]
La Croix-Rouge canadienne déploie une clinique médicale d’urgence en Jamaïque
11/11/2025
Des spécialistes humanitaires sont mobilisés pour porter secours aux personnes touchées par l’ouragan Melissa OTTAWA, Ontario, 10 nov. 2025 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne, en collaboration avec la [...]
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
11/11/2025
TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based [...]
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/11/2025
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today [...]
Burn Blend 2025 | Effective Weight Loss Supplement Read Benefits, Ingredients Lunch Burn Blend Canada & Australia
10/11/2025
Burn Blend is a natural Weight Loss Supplement that combines nature’s most effective ingredients to support focus, endurance, and metabolism. Read BurnBlend consumer reports. New York City, Nov. 10, 2025 (GLOBE NEWSWIRE [...]

Pages